Related Experiment Video
Updated: Jan 8, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Access to palliative care services within patient-sharing networks for patients with breast, colorectal and non-small
Wenyu Zhang1, Tara L Kaufmann2,3, Ashlee A Korsberg1
1Department of Biomedical Data Science, Dartmouth College Geisel School of Medicine, Lebanon, New Hampshire, USA.
Objectives:
Timely delivery of palliative care (PC) services improves outcomes for patients with cancer; however, utilisation remains low. This study aimed to determine access to PC clinicians for patients with early and advanced-stage cancer and assess collaboration with oncology physicians using patient-sharing networks.
Methods:
Using Surveillance, Epidemiology, and End Results-Medicare data (2016-2019), we identified patients with stage I-IV breast, colorectal or non-small cell lung cancer. PC encounters within 12 months after diagnosis were included. PC clinicians were defined as those with at least one PC encounter and further categorised as formally trained PC specialists or non-specialists (billing code only). Patient-sharing networks evaluated the extent of collaboration between oncology physicians and PC specialists. Direct connections were defined as physicians sharing patients with a PC specialist; indirect connections as sharing patients with another clinician who was directly connected to a PC specialist.
Results:
Among 100 891 patients, 6% received PC services, with higher rates observed for stage IV disease (15%) compared with stages I-III (3%). Only 33% of PC encounters were delivered by PC specialists (36% in stages I-III; 32% in stage IV). In 2019, 85% of medical oncologists had either a direct (16%) or indirect (69%) connection with a specialist.
Conclusions:
Patient-sharing network analysis revealed limited integration of specialty PC, with most oncologists indirectly collaborating with PC specialists. Expanding the specialist workforce and strengthening collaboration are essential to improve access and quality of PC delivery.
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Related Concept Videos
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Continuing Care
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers
Cancer Survival Analysis
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...